Self-contained device integrating nucleic acid extraction, amplification and detection
First Claim
Patent Images
1. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
- a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) amplifying said target nucleic acid on said solid phase or silica slurry with a first primer having a first label and a second primer having a second label under conditions that preferentially amplify said target nucleic acid to produce an amplification reaction mixture comprising target amplicons having said first label and said second label, wherein prior to amplification said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target amplicons within said detection chamber by a lateral flow assay, wherein said assay comprises wicking said target amplicons onto a membrane, wherein said target amplicons bind to at least a first and second reagent and at least one of said reagents is bound to said membrane, whereby when said at least two reagents are both bound to said target amplicons a visible signal is detected, wherein said amplification and said extraction take place within a first chamber of said device that is in fluid communication with said detection chamber, or said extraction takes place within a first chamber of said device and said amplification takes place in a second chamber of said device that is in fluid communication with both said first chamber and said detection chamber.
5 Assignments
0 Petitions
Accused Products
Abstract
Self-contained devices are described that integrate nucleic acid extraction, specific target amplification and detection into a single device. This integration permits rapid and accurate nucleic acid sequence detection. The invention may be used, for example, in the screening for nucleic acid sequences which may be indicative of genetic defects or contagious diseases, as well as for monitoring efficacy in the treatment of contagious diseases.
87 Citations
16 Claims
-
1. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
-
a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) amplifying said target nucleic acid on said solid phase or silica slurry with a first primer having a first label and a second primer having a second label under conditions that preferentially amplify said target nucleic acid to produce an amplification reaction mixture comprising target amplicons having said first label and said second label, wherein prior to amplification said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target amplicons within said detection chamber by a lateral flow assay, wherein said assay comprises wicking said target amplicons onto a membrane, wherein said target amplicons bind to at least a first and second reagent and at least one of said reagents is bound to said membrane, whereby when said at least two reagents are both bound to said target amplicons a visible signal is detected, wherein said amplification and said extraction take place within a first chamber of said device that is in fluid communication with said detection chamber, or said extraction takes place within a first chamber of said device and said amplification takes place in a second chamber of said device that is in fluid communication with both said first chamber and said detection chamber. - View Dependent Claims (2, 3)
-
-
4. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
-
a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) amplifying said target nucleic acid on said solid phase or silica slurry with a first primer having a first label and to a second primer under conditions that preferentially amplify said target nucleic acid to produce an amplification reaction mixture comprising singly labeled target amplicons, wherein prior to amplification said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target amplicons within said detection chamber by a lateral flow assay, wherein said assay comprises wicking said target amplicons onto a membrane, wherein said singly labeled target amplicons bind to at least a first, a second and a third reagent and at least one of said reagents is bound to said membrane, whereby when said at least three reagents are all bound to said target amplicons a visible signal is detected, wherein said amplification and extraction take place within a first chamber of said device that is in fluid communication with said first chamber, or said extraction takes place within a first chamber of said device and said amplification takes place in a second chamber that is in fluid communication with both said first chamber and said detection chamber. - View Dependent Claims (5, 6)
-
-
7. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
-
a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) amplifying said target nucleic acid on said solid phase or silica slurry with first and second complementary primers under conditions that preferentially amplify said target nucleic acid to produce an amplification reaction mixture comprising target amplicons, wherein prior to amplification said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target amplicons within said detection chamber by a lateral flow assay, wherein said assay comprises wicking said target amplicons onto a membrane, wherein said target amplicons bond to at least a first reagent, a second reagent, a third reagent, and a fourth reagent, and at least one of said reagents is bound to said membrane, whereby when said at least four reagents area all bound to said target amplicons a visible signal is detected, wherein said amplification and extraction take place within a first chamber of said device that is in fluid communication with said first chamber, or said extraction takes place within a first chamber of said device and said amplification takes place within a second chamber that is in fluid communication with both said first chamber and said detection chamber. - View Dependent Claims (8, 9)
-
-
10. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
-
a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) hybridizing said target nucleic acid to a DNA-RNA-DNA probe having a first label on the 5′
end and a second label on the 3′
end to form a reaction mixture comprising a hybridized product having a first and second label, wherein prior to hybridization said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target nucleic acid within said detection chamber by a lateral flow assay, wherein said assay comprises;
i) contacting said hybridized product with colored microparticles having first receptors bound thereto, wherein said first receptors on said microparticles are specific for and bind to said first label;
ii) contacting said microparticle-bound hybridized product with RNase H to form a mixture, wherein said RNase H cleaves said probe only if said probe is hybridized to said target nucleic acid; and
iii) contacting said mixture from step ii) with a membrane having a capture zone, wherein said capture zone comprises second receptors specific for said second label, wherein said mixture wicks along said membrane to said capture zone and a visible line does not form at said capture zone if said target nucleic acid is present in said sample.
-
-
11. A method of detecting a target nucleic acid in a sample, comprising:
-
i) extracting said target nucleic acid, wherein extraction takes place in a first tube comprising a solid phase matrix that binds said target nucleic acid, said matrix tube being positioned inside a second tube having a closed end and an open end and lid for closing the open end, said second tube further containing a reagent cell positioned within said second tube and over said first tube and containing nucleic acid amplification reagents;
ii) amplifying said target nucleic acid bound on said solid phase matrix by releasing said amplification reagents comprising a first primer having a first label and a second primer having a second label from said reagent cell into said first tube under conditions that preferentially amplify said target nucleic acid to produce a reaction mixture comprising target amplicons having said first label and said second label, wherein prior to amplification said nucleic acid present in a double-stranded form are rendered single-stranded;
iii) inserting a result stick comprising a membrane having first and second reagents disposed thereon through a seal in said cap and into said reaction mixture, wherein when said target amplicons bind to both said first and second reagents a visible signal is detected, and wherein said extraction, amplification, and detection occur while said second tube open end is closed by said lid. - View Dependent Claims (12, 13, 14)
-
-
15. A method of detecting a target nucleic acid in a sample, wherein all of said method steps take place within a multi-chambered self-contained device having at least two chambers, said method comprising:
-
a) extracting said target nucleic acid, wherein said extraction includes binding said target nucleic acid to a solid phase or silica slurry;
b) amplifying said target nucleic acid on said solid phase or silica slurry with a first primer having a first label and to a second primer under conditions that preferentially amplify said target nucleic acid to produce an amplification reaction mixture comprising singly labeled target amplicons, wherein prior to hybridization said nucleic acid present in a double-stranded form are rendered single-stranded;
c) transferring said reaction mixture to a detection chamber of said device; and
d) detecting said target amplicons within said detection chamber by a lateral flow assay, wherein said assay comprises wicking said singly labeled target amplicons onto a membrane, wherein said singly labeled target amplicons bind to at least a first and a second reagent and at least one of said reagents is bound to said membrane, whereby when said at least two reagents are all bound to said target amplicons a visible signal is detected, wherein said amplification and extraction take place within a first chamber of said device that is in fluid communication with said first chamber, or said extraction takes place within a first chamber of said device and said amplification takes place in a second chamber that is in fluid communication with both said first chamber and said detection chamber. - View Dependent Claims (16)
-
Specification